Rimegepant
Rimegepant is used to prevent and treat the symptoms of migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light). Rimegepant is in a class of medications called calcitonin gene-related peptide receptor antagonists. It works by blocking the action of a certain natural substance in the body that causes migraine headaches.
🔔 How should this medicine be used?
Rimegepant comes as an orally disintegrating tablet (tablet that dissolves quickly in the mouth) to take by mouth. If used to prevent a migraine, it is usually taken every other day. If used to treat a migraine, it is usually taken as a single dose at the first sign of a migraine headache. Do not take more than one dose in a 24-hour period. Your doctor will tell you the maximum number of migraine headaches you should treat with rimegepant tablets in a 30-day period. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take rimegepant exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Do not try to push the orally disintegrating tablet through the foil packaging. Instead, use dry hands to peel back the foil. Immediately take out the tablet and place it on or under your tongue. The tablet will quickly dissolve and can be swallowed with saliva. No water is needed to swallow disintegrating tablets.
Call your doctor if your headaches do not get better or occur more frequently after taking rimegepant.
Ask your pharmacist or doctor for a copy of the manufacturer’s information for the patient.
🔔 Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
It’s not just health insurance premiums, but also deductibles, that keep on rising. In 2018, the average deductible was $3,000 for a gold-tier family plan, $8,000 for a silver-tier family plan and $12,000 for a bronze-tier family plan, according to USC Annenberg’s Center for Health Journalism.
